Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
AIVITA Biomedical is is a medicine company develops commercial and clinical stage programs utilizing curative and regenerative medicines.
Nexcella Utilize cell therapies to create safe and effective medicines for oncology and other conditions, improving patient outcomes.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
Aspera Biomedicines is a space-accelerated biotechnology company pioneering therapies that target cancer stem cells.
Mahzi Therapeutics is a health care and biotechnology company.
Blue Gen Therapeutics Foundation is a non-profit clinical-stage biotech organization.
Luxa Biotechnology is a clinical-stage biotechnology firm developing a unique adult RPE stem cell (RPESC) therapy for dry AMD.
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.
Anova Enterprises accelerates clinical development of promising therapeutics through improved access, collaboration and data.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.
Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.
Mustang Bio is a clinical-stage biopharmaceutical company .
Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.
California Institute for Regenerative Medicine has invested in 49 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
California Institute for Regenerative Medicine's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 19 different industry categories.
Among tracked funding rounds, Kenai Therapeutics received $82.0M in a Series A round. California Institute for Regenerative Medicine's total known invested capital is $676.9M.
California Institute for Regenerative Medicine's average investment size is $14.1M across its portfolio of 49 companies.
Recent California Institute for Regenerative Medicine portfolio additions include Angiocrine Bioscience, Greenstone Biosciences, AIVITA Biomedical, Nexcella, ImmunoVec. These companies were founded in 2020 or later.